Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Andrew Atkocius"'
Autor:
Pradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, Wenjia Feng, Nadja Pejovic, Armaan Nallicheri, Peter K Harris, Katherine Dienstbach, Andrew Atkocius, Lenon Maguire, Faridi Qaium, Jeffrey J Szymanski, Brian C Baumann, Li Ding, Dengfeng Cao, Melissa A Reimers, Eric H Kim, Zachary L Smith, Vivek K Arora, Aadel A Chaudhuri
Publikováno v:
PLoS Medicine, Vol 18, Iss 8, p e1003732 (2021)
BackgroundThe standard of care treatment for muscle-invasive bladder cancer (MIBC) is radical cystectomy, which is typically preceded by neoadjuvant chemotherapy. However, the inability to assess minimal residual disease (MRD) noninvasively limits ou
Externí odkaz:
https://doaj.org/article/68ac59a93c0e4cf082db6dfecd686ee0
Autor:
Faridi Qaium, Wenjia Feng, Dengfeng Cao, Li Ding, Katherine Dienstbach, Ramandeep K. Babbra, Jeffrey J. Szymanski, Aadel A. Chaudhuri, Zachary L. Smith, Melissa A. Reimers, Brian C. Baumann, Nadja Pejovic, Vivek K. Arora, Peter K. Harris, Yi Huang, Eric H. Kim, Andrew Atkocius, Lenon Maguire, Kevin Chen, Pradeep S. Chauhan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e258-e259
Purpose/Objective(s) Standard-of-care for treating muscle-invasive bladder cancer (MIBC) typically involves radical cystectomy, which is a morbid procedure. Nonoperative treatment including chemoradiation is a standard-of-care alternative, but it req
Autor:
Joel Picus, Mark Qiao, Haley Ellis, Wenjia Feng, Aadel A. Chaudhuri, Jingqin Luo, Pradeep S. Chauhan, Katherine Dienstbach, Rachel Beck, Grace Smith, Faridi Qaium, Peter K. Harris, Russell K. Pachynski, Andrew Atkocius, Christopher G. Maher, Jeff M. Michalski, Ha X. Dang
Publikováno v:
JCO Precis Oncol
PURPOSE Cell-free DNA (cfDNA) and circulating tumor cell (CTC)–based liquid biopsies have emerged as potential tools to predict responses to androgen receptor (AR)–directed therapy in metastatic prostate cancer. However, because of complex mechan
Autor:
Pradeep S. Chauhan, Kevin Chen, Ramandeep K. Babbra, Wenjia Feng, Nadja Pejovic, Armaan Nallicheri, Peter K. Harris, Katherine Dienstbach, Andrew Atkocius, Lenon Maguire, Faridi Qaium, Jeffrey J. Szymanski, Brian C. Baumann, Li Ding, Dengfeng Cao, Melissa A. Reimers, Eric H. Kim, Zachary L. Smith, Vivek K. Arora, Aadel A. Chaudhuri
Publikováno v:
PLOS Medicine. 18:e1003876
Autor:
Vivek K. Arora, Eric H. Kim, Pradeep S. Chauhan, Ramandeep K. Babbra, Armaan Nallicheri, Faridi Qaium, Zachary L. Smith, Aadel A. Chaudhuri, Melissa A. Reimers, Peter K. Harris, Wenjia Feng, Brian C. Baumann, Katherine Dienstbach, Lenon Maguire, Andrew Atkocius, Kevin Chen
Publikováno v:
Cancer Research. 81:547-547
Objective: Standard-of-care for muscle-invasive bladder cancer (MIBC) is neoadjuvant chemotherapy followed by radical cystectomy. The inability to assess molecular residual disease (MRD) noninvasively limits our ability to offer bladder-sparing treat
Autor:
Vivek K. Arora, Brian C. Baumann, Eric H. Kim, Nadja Pejovic, Armaan Nallicheri, Aadel A. Chaudhuri, Ramandeep K. Babbra, Zachary L. Smith, Kevin Chen, Dengfeng Cao, Andrew Atkocius, Lenon Maguire, Pradeep S. Chauhan, Peter K. Harris, Faridi Qaium, Jeffrey J. Szymanski, Wenjia Feng, Katherine Dienstbach, Melissa A. Reimers, Li Ding
Publikováno v:
Journal of Clinical Oncology. 39:e16514-e16514
e16514 Background: Standard-of-care for muscle-invasive bladder cancer (MIBC) consists of neoadjuvant chemotherapy (NAC) followed by radical cystectomy. The inability to noninvasively assess minimal residual disease (MRD) after NAC limits our ability
Autor:
Pradeep S. Chauhan, Lenon Maguire, Faridi Qaium, Peter K. Harris, Vivek K. Arora, Andrew Atkocius, Wenjia Feng, Katherine Dienstbach, Nadja Pejovic, Ramandeep K. Babbra, Zachary L. Smith, Armaan Nallicheri, Aadel A. Chaudhuri
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e916
Autor:
Ha X. Dang, Rachel Beck, Peter K. Harris, Wenjia Feng, Joel Picus, Pradeep S. Chauhan, Christopher G. Maher, Jeff M. Michalski, Katherine Dienstbach, Faridi Qaium, Mark Qiao, Andrew Atkocius, Russell K. Pachynski, Jingqin Luo, Grace Smith, Aadel A. Chaudhuri, Haley Ellis
Publikováno v:
Cancer Research. 80:LB-269
Background: Liquid biopsy analysis of cell-free DNA (cfDNA) and circulating tumor cells (CTCs) have emerged as potential tools to predict response to androgen receptor (AR)-directed therapy in metastatic prostate cancer (mPCa). However, current clini
Autor:
Jeff M. Michalski, Andrew Atkocius, Joel Picus, Rachel Beck, Grace Smith, Jingqin Luo, Pradeep S. Chauhan, Mark Qiao, Wenjia Feng, Haley Ellis, Ha X. Dang, Katherine Dienstbach, Russell K. Pachynski, Faridi Qaium, Christopher G. Maher, Aadel A. Chaudhuri, Peter K. Harris
Publikováno v:
Journal of Clinical Oncology. 38:5529-5529
5529 Background: Predicting primary resistance to androgen receptor (AR)-directed therapies is critical for personalizing treatment of metastatic prostate cancer (mPCa). Analyses of liquid biopsies are potential tools but remained underutilized due t